| Original language | English |
|---|---|
| Pages | A95 |
| Publication status | Published - 1 Jan 2003 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Serevent(TM) significantly increases trough FEV(1) in COPD up to 12 months without loss of effect
- Robert Stockley
- , PJ Whitehead
- , MK Williams
- , G Hagan
Research output: Contribution to conference (unpublished) › Paper